These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18386207)

  • 1. Autism: the role of cholesterol in treatment.
    Aneja A; Tierney E
    Int Rev Psychiatry; 2008 Apr; 20(2):165-70. PubMed ID: 18386207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome.
    Tierney E; Nwokoro NA; Kelley RI
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):131-4. PubMed ID: 10899806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inborn errors of cholesterol biosynthesis.
    Kelley RI
    Adv Pediatr; 2000; 47():1-53. PubMed ID: 10959439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome.
    Sikora DM; Pettit-Kekel K; Penfield J; Merkens LS; Steiner RD
    Am J Med Genet A; 2006 Jul; 140(14):1511-8. PubMed ID: 16761297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and behavioral aspects of Smith-Lemli-Opitz syndrome.
    Diaz-Stransky A; Tierney E
    Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):295-300. PubMed ID: 23042585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome.
    Sikora DM; Ruggiero M; Petit-Kekel K; Merkens LS; Connor WE; Steiner RD
    J Pediatr; 2004 Jun; 144(6):783-91. PubMed ID: 15192627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
    Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
    Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts.
    Wassif CA; Vied D; Tsokos M; Connor WE; Steiner RD; Porter FD
    Mol Genet Metab; 2002 Apr; 75(4):325-34. PubMed ID: 12051964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
    Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
    Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smith-Lemli-Opitz syndrome and autism spectrum disorder.
    Bukelis I; Porter FD; Zimmerman AW; Tierney E
    Am J Psychiatry; 2007 Nov; 164(11):1655-61. PubMed ID: 17974928
    [No Abstract]   [Full Text] [Related]  

  • 11. Smith Lemli-Opitz syndrome: a contribution to the delineation of a cognitive/behavioral phenotype.
    De Clemente V; Vitiello G; Imperati F; Romano A; Parente I; Rosa M; Pascarella A; Parenti G; Del Giudice E
    Minerva Pediatr; 2013 Feb; 65(1):61-9. PubMed ID: 23422574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild Smith-Lemli-Opitz syndrome: further delineation of 5 Polish cases and review of the literature.
    Jezela-Stanek A; Ciara E; Malunowicz EM; Korniszewski L; Piekutowska-Abramczuk D; Popowska E; Krajewska-Walasek M
    Eur J Med Genet; 2008; 51(2):124-40. PubMed ID: 18249054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies.
    Jezela-Stanek A; Małunowicz EM; Ciara E; Popowska E; Goryluk-Kozakiewicz B; Spodar K; Czerwiecka M; Jezuita J; Nowaczyk MJ; Krajewska-Walasek M
    Clin Genet; 2006 Jan; 69(1):77-85. PubMed ID: 16451140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome.
    Tierney E; Nwokoro NA; Porter FD; Freund LS; Ghuman JK; Kelley RI
    Am J Med Genet; 2001 Jan; 98(2):191-200. PubMed ID: 11223857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis.
    Waye JS; Eng B; Nowaczyk MJ
    Prenat Diagn; 2007 Jul; 27(7):638-40. PubMed ID: 17441222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS).
    Elias ER; Irons MB; Hurley AD; Tint GS; Salen G
    Am J Med Genet; 1997 Jan; 68(3):305-10. PubMed ID: 9024564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of cholesterol metabolism in autism spectrum disorders.
    Tierney E; Bukelis I; Thompson RE; Ahmed K; Aneja A; Kratz L; Kelley RI
    Am J Med Genet B Neuropsychiatr Genet; 2006 Sep; 141B(6):666-8. PubMed ID: 16874769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the behavior of cholesterol and selected derivatives in mixed sterol-phospholipid Langmuir monolayers: a fluorescence microscopy study.
    Berring EE; Borrenpohl K; Fliesler SJ; Serfis AB
    Chem Phys Lipids; 2005 Jul; 136(1):1-12. PubMed ID: 15904906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of DHCR7 mutations in Slovak patients with Smith-Lemli-Opitz syndrome and detection of common mutations by PCR-based assays.
    Kolejáková K; Petrovic R; Futas J; Turcáni P; Durovcíková D; Chandoga J
    Gen Physiol Biophys; 2009 Mar; 28(1):8-15. PubMed ID: 19390132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smith-Lemli-Opitz syndrome and other disorders of cholesterol biosynthesis: An introduction.
    Nowaczyk MJ; Cunniff C
    Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):239-41. PubMed ID: 23042602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.